跳至主要内容
临床试验/JPRN-UMIN000008261
JPRN-UMIN000008261已完成未知

Evaluation of efficacy in endoscopic submucosal dissection to early gastric cancer, early esophageal cancer, and/or early pharyngeal cancer by new device "Nanoshooter". - Evaluation of efficacy in endoscopic submucosal dissection to early gastric cancer, early esophageal cancer, and/or early pharyngeal cancer by new device "Nanoshooter".

Kanazawa Medical University0 个研究点目标入组 75 人开始时间: 2012年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The exclusion criteria. 1)The patient who repeats hematemesis. 2)The patient who has a history of allergy to the use drug. 3)The patient that the withdrawal of coagulant and/or antiplatelet agent is impossible. 4)The patient with bad physical status. 5)The patient who cannot do to informed consent. 6)The patient who was considered ineligible by the investigators.

研究者

相似试验

Evaluation of efficacy in endoscopic submucosal... | 临床试验